Story courtesy of ABC News
More than 200 South Australians have taken part in a cutting-edge trial set to improve the diagnosis of Parkinson’s.
The SA-first trial (using one of only two high-tech cyclotron machines nationally) involves injecting people with fluorinated dopamine (F-Dopa) which then highlights the dopamine in their brain during a scan.
A biobank can then be built to see how this presents differently in people with and without Parkinson’s – improving future diagnosis and treatment.
The Hospital Research Foundation Group is proud to be providing a $300,000 grant for the trial, which involves a collaboration between our Parkinson’s charity, SAHMRI and Dr Jones & Partners Medical Imaging.
